You searched for Side Effects Public Media - Page 16 of 20 - California Healthline

Another Cause Of Doctor Burnout: Being Forced To Give Immigrants Unequal Care

By Jake Harper, Side Effects Public Media May 31, 2018

Undocumented patients with kidney disease often can’t get treatment unless they are in a state of emergency. This bothers clinicians who want to treat all patients equally.

Reversing An Overdose Isn’t Complicated, But Getting The Antidote Can Be

By Jake Harper, Side Effects Public Media May 16, 2018

Last month, U.S. Surgeon General Jerome Adams urged more Americans to carry and learn to use naloxone, which can save someone from an opioid overdose. But the drug, brand-name Narcan, can be difficult to get and expensive.

Some Academics Quietly Take Side Jobs Helping Tobacco Companies In Court

By Blake Farmer, Nashville Public Radio November 12, 2019

Faced with lawsuits from sick smokers, tobacco firms argue the health risks were “common knowledge” for decades, and they often pay professors to help make that point as expert witnesses.

Pharma Sells States On ‘Netflix Model’ To Wipe Out Hep C. But At What Price?

By JoNel Aleccia and Barbara Feder Ostrov and Donna Gordon Blankinship October 25, 2019

Manufacturers of lucrative drugs say they’re offering discounts off the high sticker prices ― but taxpayers footing the big bills might never know what the state is paying or if it’s getting a good deal.

Omissions On Death Certificates Lead To Undercounting Of Opioid Overdoses

By Jake Harper, Side Effects Public Media March 29, 2018

Standards for how to investigate and report on overdoses vary widely across states and counties. As a result, opioid overdose deaths often go overlooked in the data reported to the federal government.

A Million-Dollar Marketing Juggernaut Pushes 3D Mammograms

By Liz Szabo October 22, 2019

Companies are aggressively touting 3D mammograms, although there’s no evidence they save lives.

Must-Reads Of The Week From Brianna Labuskes

By Brianna Labuskes August 23, 2019

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.

FDA Keeps Brand-Name Drugs On A Fast Path To Market ― Despite Manufacturing Concerns

By Sydney Lupkin November 4, 2019

The agency approved Gilead’s “game changer” hepatitis C cure, bypassing concerns raised by its own federal inspectors. The problems they found at the company’s main U.S. drug-testing laboratory in Foster City, Calif., were so bad, they recommended withholding approval.

Must-Reads Of The Week From Brianna Labuskes

By Brianna Labuskes July 19, 2019

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.

Mysterious Vaping Lung Injuries May Have Flown Under Regulatory Radar

By Sydney Lupkin and Anna Maria Barry-Jester August 27, 2019

Doctors who saw patients with a mysterious lung illness in the past suspected vaping as the cause but didn’t know where to report such cases. “It wasn’t that I didn’t want to report it, it’s that there’s no pathway,” said one California pulmonologist.

Filter Results